glp 1 agonist therapy Five Unexpected New Uses for GLP-1 Receptor Agonists GLP-1 Receptor Agonists in Solid

17 Patients should discuss with their providers strategies to improve glucose control such as taking insulin more often, changing the type of insulin they use, taking insulin after meals instead of before, or checking blood glucose levels more frequently after eating to determine when insulin admin-istration is necessary

Efficacy and tolerability of tirzepatide, a dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes: A 12-week, randomized, double-blind, placebo-controlled study to evaluate different dose-escalation regimens

Thus, following the example of cancer, drug therapy could precede bariatric surgery in order to render it safer and more feasible, but could also follow if the results are not satisfactory

PMCID: PMC13080939

The oral form of semaglutide, Rybelsus , further expands its reach, offering a non-injectable option, which appeals to a larger subset of patients who are hesitant about injections